APA (7th ed.) Citation

Norikane, T., Fujimoto, K., Matsukawa, H., Manabe, Y., Murao, M., Morita, R., . . . Nishiyama, Y. (2025). Predicting pathological response to neoadjuvant chemoradiotherapy in resectable and borderline resectable pancreatic ductal adenocarcinoma: A comparative study of 18F-FLT and 18F-FDG PET. EJNMMI Research, 15(1), 1. https://doi.org/10.1186/s13550-025-01342-3

Chicago Style (17th ed.) Citation

Norikane, Takashi, et al. "Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Comparative Study of 18F-FLT and 18F-FDG PET." EJNMMI Research 15, no. 1 (2025): 1. https://doi.org/10.1186/s13550-025-01342-3.

MLA (9th ed.) Citation

Norikane, Takashi, et al. "Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Comparative Study of 18F-FLT and 18F-FDG PET." EJNMMI Research, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1186/s13550-025-01342-3.